Supreme Court Blocks Lower Court Order on Mifepristone Access
The US Supreme Court has issued an emergency order indefinitely blocking a lower court ruling that sought to restrict access to mifepristone, a commonly used abortion medication. This decision in Danco Laboratories v. Louisiana ensures the drug remains accessible while the case undergoes full litigation, likely keeping it available until at least June 2027. The order prevents the Fifth Circuit Court of Appeals from enforcing restrictions on the drug's distribution, particularly via mail. While the Court did not disclose individual votes, Justices Clarence Thomas and Samuel Alito publicly dissented. Thomas characterized the pharmaceutical manufacturers as a criminal enterprise under the Comstock Act, while Alito alleged an unlawful conspiracy. This marks the second time the Supreme Court has intervened to protect mifepristone access, following a 2024 ruling that dismissed a similar challenge on jurisdictional grounds. The decision provides temporary relief for abortion providers and patients amid ongoing legal battles over reproductive rights in the United States.
Editorial responsibility
- No named human review is recorded for this page.
- Reports are grouped by semantic similarity and deterministic rules. Language models may assist titles, summaries, translation and cross-source analysis; the page itself is projected from evidence records.
- Current automated evidence projection